Epics Therapeutics

Developer of small molecules to treat cancer

placeCharleroi, Wallonia, Belgium calendar_todayFounded 2018 groups30 employees language epicstherapeutics.com

Registered entities

Innovation

9 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 453 times.

YearFilings
20163
20192
20202
20212
20222
20231
20243
20252
20263

Social engagement

Social engagement: 1.8K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Array, Array.

Investor typeCountShare
Venture capital330%
Private equity330%
Other / undisclosed440%

Recent activity

22 Apr 2026
Event
AACR Annual Meeting 2026
21 Apr 2026
Event
26th Bio€quity Europe conference
18 Mar 2026
Partnership
AsedaSciences®
Coming soon